Workflow
Peptide-based proteolysis targeting chimeras (P-PROTACs)
icon
Search documents
Salarius Pharmaceuticals(SLRX) - Prospectus(update)
2025-10-21 16:09
As filed with the Securities and Exchange Commission on October 21, 2025 Registration No. 333-284368 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 7 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SALARIUS PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) 2450 Holcombe Blvd. Suite X Houston, TX 77021 713 ...
Salarius Pharmaceuticals(SLRX) - Prospectus(update)
2025-08-08 00:50
As filed with the Securities and Exchange Commission on August 7, 2025 Registration No. 333-284368 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 5 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SALARIUS PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Copies to: Andrew L. Strong, Esq. Stephen M. Nicolai, Esq. Hogan Lovells US LLP 609 Main Street, Suite 4200 Houston, TX 77002 (713) 632-1400 Jeffrey Kuras, Esq. Honigman L ...